These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 13073811

  • 1. [Treatment of hyperthyroidosis with 1-methyl-2-mercaptiomidazol (mercazole)].
    WURTH K.
    Praxis; 1953 Apr 23; 42(17):331-3. PubMed ID: 13073811
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of hyperthyroidism with 1-methyl-2-mercaptoimidazole].
    KLEIN E, WIEDENMANN U.
    Dtsch Med Wochenschr; 1953 Jun 12; 78(24):877-8. PubMed ID: 13068021
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of hyperthyroidism with methimazole].
    PLAMONDON CA, WISWELL JG, ASPER SP.
    Laval Med; 1952 Nov 12; 17(9):1208-19. PubMed ID: 13024096
    [No Abstract] [Full Text] [Related]

  • 4. [Experiences with 1-methyl-2-mercaptoimidazole (favistan)].
    REIS H.
    Munch Med Wochenschr; 1955 Jul 15; 97(28):903-4. PubMed ID: 13265622
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experiences with 1-methyl-2-mercaptoimidazole in the treatment of thyrotoxicosis].
    KILPINEN O.
    Duodecim; 1952 Jul 15; 68(11):967-71. PubMed ID: 13033768
    [No Abstract] [Full Text] [Related]

  • 6. Experience with methimazole (tapazole) in the treatment of hyperthyroidism; a report of thirty-five cases.
    HALLMAN BL, BONDY PK.
    Am J Med; 1951 Dec 15; 11(6):724-29. PubMed ID: 14902842
    [No Abstract] [Full Text] [Related]

  • 7. Variations in the response of individuals of different ages to an antithyroid compound (methimazole).
    McGAVACK TH, CHEVALLEY J, PEARSON S.
    J Am Geriatr Soc; 1955 Feb 15; 3(2):96-105. PubMed ID: 14353621
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methimazole and carbimazole in hyperthyroidism: a comparison by a double blind technique.
    McGAVACK TH.
    Am J Med Sci; 1959 Jul 15; 238(1):1-12. PubMed ID: 13661169
    [No Abstract] [Full Text] [Related]

  • 10. [Experience with the thyroid antagonist favistan].
    KLEINDL K.
    Med Klin; 1955 Apr 15; 50(15):672-4. PubMed ID: 14383176
    [No Abstract] [Full Text] [Related]

  • 11. A four-year study of the treatment of hyperthyroidism with methimazole.
    CHEVALLEY J, McGAVACK TH, KENIGSBERG S, PEARSON S.
    J Clin Endocrinol Metab; 1954 Aug 15; 14(8):948-60. PubMed ID: 13183988
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyrotoxicosis treated with 2-carbethoxythio-1-methylglyoxaline (neo mercazole).
    POATE H.
    Lancet; 1953 May 02; 1(6766):879-81. PubMed ID: 13045431
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline; report of 120 cases.
    DONIACH D.
    Lancet; 1953 May 02; 1(6766):873-9. PubMed ID: 13045430
    [No Abstract] [Full Text] [Related]

  • 16. Antithyroid therapy: clinical trials with mercazole.
    ISBISTER J, RUNDLE FF.
    Med J Aust; 1954 Jan 16; 41(1 3):78-81. PubMed ID: 13132158
    [No Abstract] [Full Text] [Related]

  • 17. [Immediate results with 1-methyl-2-mercaptoimidazole in hyperthyroidism].
    ROJAS MUJICA G, DIAZ DE VALDES H.
    Rev Med Chil; 1952 Mar 16; 80(3):159-63. PubMed ID: 14942114
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of thyrotoxicosis with mercazole].
    VASIL'EVA AG.
    Probl Endokrinol Gormonoter; 1957 Mar 16; 3(1):69-72. PubMed ID: 13453366
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subclinical hyperthyroidism.
    Parker L.
    N Engl J Med; 2002 Jan 03; 346(1):67-8. PubMed ID: 11778009
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.